lebrikizumab (MILR1444A)

DRUG3 trials

Sponsors

Genentech, Inc.

Conditions

Allergic AsthmaAsthma

Phase 2

A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

CompletedNCT00781443

Genentech, Inc.Allergic Asthma

Start: 2008-12-31Updated: 2010-05-06

A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids

CompletedNCT00930163

Genentech, Inc.Asthma

Start: 2009-07-31End: 2010-09-30Updated: 2016-11-29

A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids

CompletedNCT00971035

Genentech, Inc.Asthma

Start: 2009-11-30End: 2011-02-28Updated: 2016-11-29

Related Papers

The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge

Clinical & Experimental Allergy2013-10-17125 citations

Lebrikizumab treatment in adults with asthma.

2011-08-031108 citations